<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">34614220</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>28</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>28</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1600-0560</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>49</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of cutaneous pathology</Title>
          <ISOAbbreviation>J Cutan Pathol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Next-generation sequencing confirms T-cell clonality in a subset of pediatric pityriasis lichenoides.</ArticleTitle>
        <Pagination>
          <StartPage>252</StartPage>
          <EndPage>260</EndPage>
          <MedlinePgn>252-260</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/cup.14143</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Pityriasis lichenoides (PL) is a papulosquamous disease that affects both adults and children. Previous studies have shown a subset of this entity to have clonal T-cell populations via PCR-based assays. In this study, we sought to implement next-generation sequencing (NGS) as a more sensitive and specific test to examine for T-cell clonality within the pediatric population.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We identified 18 biopsy specimens from 12 pediatric patients with clinical and histopathologic findings compatible with PL. Patient demographics, clinical features, management, and histopathologic findings were reviewed. All specimens were analyzed for clonality with NGS of T-cell receptor beta (TRB) and gamma (TRG) genes.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 12 patients, 9 (75%) had complete resolution of lesions at the time of data collection (mean follow-up 31 months). The remaining three patients significantly improved with methotrexate (with or without acitretin). Interestingly, 7 of 12 patients (58%) and 9 of 17 biopsy specimens (53%) showed evidence of T-cell clonality. Two patients showed matching TRB clones from different anatomic sites.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">T-cell clonality is a common finding in PL, probably representing a "reactive clonality" rather than a true lymphoproliferative disorder. Clonality alone cannot be used as a means to distinguish PL from lymphomatoid papulosis or cutaneous lymphoma.</AbstractText>
          <CopyrightInformation>© 2021 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Raghavan</LastName>
            <ForeName>Shyam S</ForeName>
            <Initials>SS</Initials>
            <Identifier Source="ORCID">0000-0002-3816-1542</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, University of Virginia Medical Center, Charlottesville, Virginia, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Jennifer Y</ForeName>
            <Initials>JY</Initials>
            <Identifier Source="ORCID">0000-0002-2537-1081</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, Stanford University Medical Center, Stanford, California, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gru</LastName>
            <ForeName>Alejandro A</ForeName>
            <Initials>AA</Initials>
            <Identifier Source="ORCID">0000-0002-2573-8074</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, University of Virginia Medical Center, Charlottesville, Virginia, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Marqueling</LastName>
            <ForeName>Ann L</ForeName>
            <Initials>AL</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, Stanford University Medical Center, Stanford, California, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Teng</LastName>
            <ForeName>Joyce M C</ForeName>
            <Initials>JMC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, Stanford University Medical Center, Stanford, California, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Brown</LastName>
            <ForeName>Ryanne A</ForeName>
            <Initials>RA</Initials>
            <Identifier Source="ORCID">0000-0001-9099-7227</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, Stanford University Medical Center, Stanford, California, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, Stanford University Medical Center, Stanford, California, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Novoa</LastName>
            <ForeName>Roberto A</ForeName>
            <Initials>RA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, Stanford University Medical Center, Stanford, California, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, Stanford University Medical Center, Stanford, California, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kim</LastName>
            <ForeName>Youn</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, Stanford University Medical Center, Stanford, California, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zehnder</LastName>
            <ForeName>James</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, Stanford University Medical Center, Stanford, California, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Bing Melody</ForeName>
            <Initials>BM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, Stanford University Medical Center, Stanford, California, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rieger</LastName>
            <ForeName>Kerri E</ForeName>
            <Initials>KE</Initials>
            <Identifier Source="ORCID">0000-0002-4436-2471</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, Stanford University Medical Center, Stanford, California, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, Stanford University Medical Center, Stanford, California, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Cutan Pathol</MedlineTA>
        <NlmUniqueID>0425124</NlmUniqueID>
        <ISSNLinking>0303-6987</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003001" MajorTopicYN="Y">Cloning, Molecular</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019674" MajorTopicYN="N">Genes, T-Cell Receptor beta</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019675" MajorTopicYN="N">Genes, T-Cell Receptor gamma</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D059014" MajorTopicYN="N">High-Throughput Nucleotide Sequencing</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017514" MajorTopicYN="N">Pityriasis Lichenoides</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">T-cell clonality</Keyword>
        <Keyword MajorTopicYN="N">high-throughput sequencing</Keyword>
        <Keyword MajorTopicYN="N">next-generation sequencing</Keyword>
        <Keyword MajorTopicYN="N">pityriasis lichenoides</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>8</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>5</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>9</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>29</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>6</Day>
          <Hour>17</Hour>
          <Minute>34</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34614220</ArticleId>
        <ArticleId IdType="doi">10.1111/cup.14143</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Patterson J. Chapter 8: the vasculopathic reaction pattern. In: Patterson J, ed. Weedon's Skin Pathology. 5th ed. Elsevier; 2020:261-263.</Citation>
        </Reference>
        <Reference>
          <Citation>Borra T, Custrin A, Saggini A, et al. Pityriasis lichenoides, atypical pityriasis lichenoides, and related conditions: a study of 66 cases. Am J Surg Pathol. 2018;42(8):1101-1112.</Citation>
        </Reference>
        <Reference>
          <Citation>Weinberg JM, Kristal L, Chooback L, Honig PJ, Kramer EM, Lessin SR. The clonal nature of pityriasis lichenoides. Arch Dermatol. 2002;138(8):1063-1067.</Citation>
        </Reference>
        <Reference>
          <Citation>Vonderheid EC, Kadin ME, Telang GH. Commentary about papular mycosis fungoides, lymphomatoid papulosis and lymphomatoid pityriasis lichenoides: more similarities than differences. J Cutan Pathol. 2016;43(4):303-312.</Citation>
        </Reference>
        <Reference>
          <Citation>Vonderheid EC, Kadin ME, Gocke CD. Lymphomatoid papulosis followed by pityriasis lichenoides: a common pathogenesis? Am J Dermatopathol. 2011;33(8):835-840.</Citation>
        </Reference>
        <Reference>
          <Citation>Heng YK, Koh MJA, Giam YC, Tang MBY, Chong WS, Tan SH. Pediatric mycosis fungoides in Singapore: a series of 46 children. Pediatr Dermatol. 2014;31(4):477-482.</Citation>
        </Reference>
        <Reference>
          <Citation>Plaza JA, Morrison C, Magro CM. Assessment of TCR-beta clonality in a diverse group of cutaneous T-cell infiltrates. J Cutan Pathol. 2008;35(4):358-365.</Citation>
        </Reference>
        <Reference>
          <Citation>Zaaroura H, Sahar D, Bick T, Bergman R. Relationship between pityriasis lichenoides and mycosis fungoides: a clinicopathological, immunohistochemical, and molecular study. Am J Dermatopathol. 2018;40(6):409-415.</Citation>
        </Reference>
        <Reference>
          <Citation>Holm N, Flaig MJ, Yazdi AS, Sander CA. The value of molecular analysis by PCR in the diagnosis of cutaneous lymphocytic infiltrates. J Cutan Pathol. 2002;29(8):447-452.</Citation>
        </Reference>
        <Reference>
          <Citation>Magro C, Crowson AN, Kovatich A, Burns F. Pityriasis lichenoides: a clonal T-cell lymphoproliferative disorder. Hum Pathol. 2002;33(8):788-795.</Citation>
        </Reference>
        <Reference>
          <Citation>Magro C, Crowson A, Morrison C, Li J. Pityriasis lichenoides chronica: stratification by molecular and phenotypic profile. Hum Pathol. 2007;38(3):479-490.</Citation>
        </Reference>
        <Reference>
          <Citation>Chen M, Deng A, Crowson AN, et al. Assessment of T-cell clonality via T-cell receptor-rearrangements in cutaneous T-cell-dominant infiltrates using polymerase chain reaction and single-stranded DNA conformational polymorphism assay. Appl Immunohistochem Mol Morphol. 2004;12(4):7-379.</Citation>
        </Reference>
        <Reference>
          <Citation>Dereure O, Levi E, Kadin ME. T-cell clonality in pityriasis lichenoides et varioliformis acuta: a heteroduplex analysis of 20 cases. Arch Dermatol. 2000;136(12):1483-1486.</Citation>
        </Reference>
        <Reference>
          <Citation>Kadin M. T-cell clonality in pityriasis lichenoides: evidence for a premalignant or reactive immune disorder? Arch Dermatol. 2002;138(8):1089-1090.</Citation>
        </Reference>
        <Reference>
          <Citation>Kim JE, Yun WJ, Mun S-K, et al. Pityriasis lichenoides et varioliformis acuta and pityriasis lichenoides chronica: comparison of lesional T-cell subsets and investigation of viral associations. J Cutan Pathol. 2011;38(8):649-656.</Citation>
        </Reference>
        <Reference>
          <Citation>Cozzio A, Hafner J, Kempf W, et al. Febrile ulceronecrotic Mucha-Habermann disease with clonality: a cutaneous T-cell lymphoma entity? J Am Acad Dermatol. 2004;51(6):1014-1017.</Citation>
        </Reference>
        <Reference>
          <Citation>Shieh S, Mikkola DL, Wood GS. Differentiation and clonality of lesional lymphocytes in pityriasis lichenoides chronica. Arch Dermatol. 2001;137(3):305-308.</Citation>
        </Reference>
        <Reference>
          <Citation>Sufficool KE, Lockwood CM, Abel HJ, et al. T-cell clonality assessment by next-generation sequencing improves detection sensitivity in mycosis fungoides. J Am Acad Dermatol. 2015;73(2):228-236.e2.</Citation>
        </Reference>
        <Reference>
          <Citation>Weng W-K, Armstrong R, Arai S, Desmarais C, Hoppe R, Kim YH. Minimal residual disease monitoring with high-throughput sequencing of T cell receptors in cutaneous T cell lymphoma. Sci Transl Med. 2013;5(214):214ra171.</Citation>
        </Reference>
        <Reference>
          <Citation>Kirsch IR, Watanabe R, O'Malley JT, et al. TCR sequencing facilitates diagnosis and identifies mature T cells as the cell of origin in CTCL. Sci Transl Med. 2015;7(308):308ra158.</Citation>
        </Reference>
        <Reference>
          <Citation>Menzinger S, Frassati-Biaggi A, Leclerc-Mercier S, Bodemer C, Molina TJ, Fraitag S. Pityriasis lichenoides: a large histopathological case series with a focus on adnexotropism. Am J Dermatopathol. 2020;42(1):1-10.</Citation>
        </Reference>
        <Reference>
          <Citation>Wahie S, Hiscutt E, Natarajan S, Taylor A. Pityriasis lichenoides: the differences between children and adults. Br J Dermatol. 2007;157(5):941-945.</Citation>
        </Reference>
        <Reference>
          <Citation>Thapa DR, Tonikian R, Sun C, et al. Longitudinal analysis of peripheral blood T cell receptor diversity in patients with systemic lupus erythematosus by next-generation sequencing. Arthritis Res Ther. 2015;17(1):132.</Citation>
        </Reference>
        <Reference>
          <Citation>Chang JC, Smith LR, Froning KJ, et al. Persistence of T-cell clones in psoriatic lesions. Arch Dermatol. 1997;133(6):703-708.</Citation>
        </Reference>
        <Reference>
          <Citation>Lukowsky A, Muche JM, Sterry W, Audring H. Detection of expanded T cell clones in skin biopsy samples of patients with lichen sclerosus et atrophicus by T cell receptor-gamma polymerase chain reaction assays. J Invest Dermatol. 2000;115(2):254-259.</Citation>
        </Reference>
        <Reference>
          <Citation>Brooklyn TN, Williams AM, Dunnill MGS, Probert CS. T-cell receptor repertoire in pyoderma gangrenosum: evidence for clonal expansions and trafficking. Br J Dermatol. 2007;157(5):960-966.</Citation>
        </Reference>
        <Reference>
          <Citation>Nihal M, Mikkola D, Horvath N, et al. Cutaneous lymphoid hyperplasia: a lymphoproliferative continuum with lymphomatous potential. Hum Pathol. 2003;34(6):617-622.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
